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FADD, caspase-8, and cFLIP regulate the outcome
of cell death signaling. Mice that constitutively lack
these molecules die at an early embryonic age,
whereas tissue-specific constitutive deletion of
FADD or caspase-8 results in inflammatory skin dis-
ease caused by increased necroptosis. The function
of cFLIP in the skin in vivo is unknown. In contrast
to tissue-specific caspase-8 knockout, we show
that mice constitutively lacking cFLIP in the
epidermis die around embryonic days 10 and 11.
When cFLIP expression was abrogated in adult skin
of cFLIPfl/fl-K14CreERtam mice, severe inflammation
of the skin with concomitant caspase activation and
apoptotic, but not necroptotic, cell death developed.
Apoptosis was dependent of autocrine tumor necro-
sis factor production triggered by loss of cFLIP.
In addition, epidermal cFLIP protein was lost in
patients with severe drug reactions associated with
epidermal apoptosis. Our data demonstrate the
importance of cFLIP for the integrity of the epidermis
and for silencing of spontaneous skin inflammation.
INTRODUCTION
Death receptor (DR) activation initiates the formation of a death-
inducing signaling complex (DISC) that contains the adaptor
protein FADD, cellular FLICE-inhibitory protein (cFLIP), and the
initiator cysteinyl-aspartate specific protease (caspase)-8, a
close homolog of cFLIP with proteolytic activity (Dickens et al.,
2012). Studies in mice deficient for caspase-8, cFLIP, or FADD
demonstrated the essential role of these molecules in embryonicCdevelopment (Varfolomeev et al., 1998; Yeh et al., 1998, 2000).
Recent data suggest that within intracellular signaling platforms,
beyond activation of apoptosis, the core components FADD and
caspase-8, and the proteolytic activity of caspase-8, play an
equally important role in inactivation of necroptosis, although
the exact molecular mechanism remains to be determined. The
impact of cFLIP for these divergent signals remains to be
resolved in vivo.
In previous studies, loss of central elements of the apoptotic
machinery in the skin, such as caspase-8 (Kovalenko et al.,
2009) or FADD (Bonnet et al., 2011), unexpectedly resulted in
severe inflammatory skin disease. In this context, the role of
cFLIP as a direct binding partner of caspase-8 is not yet fully un-
derstood. A current hypothesis is that activity of the caspase-8/
cFLIPL heterodimer within different signaling platforms is able to
inactivate pronecroptotic signaling (Geserick et al., 2009; Oberst
et al., 2011). Furthermore, intracellular localization of caspase-
8’s activity within or outside of the signaling platforms, as well
as its proteasomal degradation-dependent half-life in the cyto-
plasm (Gonzalvez et al., 2012), is of major importance for the
differential regulation of apoptosis versus necroptosis. These
aspects of caspase-8 activity are critically regulated by cFLIP
and its different isoforms (Feoktistova et al., 2011; Geserick
et al., 2009). Thus, both apoptosis and necroptosis signaling
pathways are closely intertwined in a number of caspase-8
and cFLIP isoform-containing intracellular death platforms that
are involved in the outcome of cellular stress signaling in a num-
ber of organs, including the skin.
We previously noted a strong expression of cFLIP in the basal
layer of human epidermis (Armbruster et al., 2009), suggesting
an important role of cFLIP in the epidermis. We thus investigated
the role of cFLIP in vivo by generating and analyzing epidermis-
specific, cFLIP-deficient animals. Of note, whereas prenatal
constitutive deletion of cFLIP in the skin resulted in predominant
embryonic lethality, postnatal acute deletion of cFLIP in keratin
14 (K14)-positive keratinocytes induced severe dysregulationell Reports 5, 397–408, October 31, 2013 ª2013 The Authors 397
of epidermal homeostasis. We found that an early critical event
leading to cell death in cFLIP-deficient keratinocytes is TNF-
dependent apoptosis. In addition, studies of cFLIP in different
skin diseases demonstrated a reduction of cFLIP protein expres-
sion in conditions associated with epidermal cell death (dysker-
atosis). Our results thus suggest that epidermal loss of cFLIP
may be a prerequisite for the life-threatening cell death seen in
patients with toxic epidermal necrolysis (TEN)/Stevens-Johnson
syndrome (SJS) or erythema exudativummultiforme (EEM). Alto-
gether, our findings highlight the importance of cFLIP in skin
homeostasis and apoptosis protection, whereas under those
conditions, necroptosis seems to be of lesser relevance.
RESULTS
Constitutive Epidermal Deficiency of cFLIP Results in
Embryonic Lethality
We generated skin-specific cFLIP knockout mice by using Cre/
loxP-mediated recombination for conditional gene targeting. In
order to specifically target cFLIP in the basal layer of epidermis,
we used mice strains that express Cre recombinase (Cre) under
the control of human K14 promoter (Hafner et al., 2004). How-
ever, a high rate of abortion (60%) in embryos from embryonic
day 11 (E11) to E14 was detected (data not shown), and no prog-
eny was born when cFLIP was deleted by K14-dependent Cre
expression (Table S1). Western blot analysis of epidermal
extracts from the few cFLIPfl/fl-K14-Cre animals that were born
did not reveal epidermal loss of cFLIP, indicating that these
animals may have silenced K14-dependent Cre expression or
counter selected against cFLIP-deleted keratinocytes during
earlier phases of embryogenesis (data not shown). The embry-
onic lethality of epidermal cFLIPfl/fl-K14Cre mice precluded a
vigorous analysis of the role of cFLIP in the skin, but indicated
the relevance of cFLIP for epidermal homeostasis during embry-
onic development.
Inducible Postnatal Deletion of cFLIP Leads to Dramatic
Dermal Inflammation and Epidermal Cell Death
We next generated K14CreERtam transgene mouse strains that
allowed temporally and spatially controlled expression of cFLIP
in keratinocytes. The transgene expresses a fusion protein
between Cre and a tamoxifen- or 4-hydroxytamoxifen (4-HT)-
responsive hormone-binding domain of the estrogen receptor
(Vasioukhin et al., 1999). All animals with the cFLIPfl/fl-
K14CreERtam genotype were born at the expectedMendelian ra-
tio, and showed normal health and fertility, and no indication of
cFLIP deletion in the absence of 4-HT as determined by geno-
typing PCR (an example of an initial set of genotyped progeny
is shown in Table S2). To analyze the effect of inducible cFLIP
deletion in restricted skin areas of adult animals, cFLIPfl/fl-
K14CreERtam and cFLIP+/+-K14CreERtam control mice were de-
pilated and subsequently treated with tamoxifen (2.5 mg/mice)
for 5 consecutive days. Shortly after initiation of tamoxifen treat-
ment, cFLIPfl/fl-K14CreERtam mice, but not control mice, devel-
oped macroscopic skin abnormalities starting with skin redness.
At later time points, the animals showed yellowish crusts in
treated skin regions (Figures 1A and S1). These changes quickly
progressed to severe alterations and macroscopically detect-398 Cell Reports 5, 397–408, October 31, 2013 ª2013 The Authorsable inflammation and thickening of the skin at later time points
(Figure 1A). This skin disease was independent of bacterial over-
growth in skin with a perturbed skin barrier, as indicated by the
same kinetics and severity of disease in animals treated with
daily topical disinfection (Figure S1B). Successful deletion of
the floxed cFLIP alleles in the epidermis was confirmed by multi-
plex PCR (Figures 1B and 1C). Of interest, 12 weeks after the
treatment, most of the depilated hair had regrown in ethanol-
treated areas, whereas local scarring alopecia was still evident
in tamoxifen-treated skin of the same animals, indicating that
loss of epidermal cFLIP also results in irreversible loss of hair fol-
licles and scarring (Figure S1C).
Immunohistological analysis of skin sections from cFLIPfl/fl-
K14CreERtam and control mice was performed. Despite the de-
tected loss of cFLIP protein expression predominantly in the
basal layer 48 hr after initiation of tamoxifen treatment (T48h),
we were unable to detect any overt histological differences
between cFLIPfl/fl-K14CreERtam and the respective control
mice at this time point (Figure 1D). Moreover, at that stage,
epidermal differentiation appeared normal, as demonstrated
by the expression of K14 and K10 in basal and suprabasal kera-
tinocytes, respectively. Staining with the terminal differentiation
marker loricrin or the proliferationmarker Ki67 excluded differen-
tiation or proliferation defects of the epidermis at these early time
points (Figures 1D, S2A, and S2D). However, at T72h, cFLIPfl/fl-
K14CreERtam mice fully lacked cFLIP expression in the
epidermis (Figures 1D, 1E, and S3). Furthermore, we detected
marked acanthosis of the epidermis accompanied by a dramat-
ically increased dermal infiltration of neutrophilic granulocytes
and lymphocytes concomitantly with a regular occurrence of
eosinophilic keratinocytes with pyknotic (commonly known as
dyskeratotic) nuclei (Figures 1D and 1E; Schwarz et al., 1995).
Although high K14 expression was found, reduced expression
of K10 and loricrin in the epidermis of cFLIPfl/fl-K14CreERtam
mice was accompanied by increased keratinocyte proliferation
at these time points (Figures S2A and S2D). At the T72h stage,
the skin of tamoxifen-treated cFLIPfl/fl-K14CreERtam mice dis-
played both patchy areas of epidermal hyperplasia and dysre-
gulated keratinocyte differentiation (Figure 1D). At T96h, the
epidermis of cFLIPfl/fl-K14CreERtam animals was fully disinte-
grated in large regions, along with extensive infiltration of
inflammatory cells in the dermis, abundant pustules containing
neutrophils, and the frequent appearance of subepidermal blis-
tering (Figure 1F). Taken together, these results indicate that
epidermis-specific inducible deletion of FLIP resulted in com-
plete loss of K14- and K10-positive cells at late time points,
consistent with complete loss of epidermis due to extensive
cell death. Thus, based on acute postnatal ablation of cFLIP,
our data demonstrate that cFLIP is critical for epidermal
homeostasis.
The early skin erythema after tamoxifen application was sug-
gestive of increased inflammation of knockout, but not diluent-
treated, mice (Figure S1). Our analysis of the inflammatory
response after keratinocyte-specific loss of cFLIP in the
epidermis detected early development of a T cell- and gran-
ulocyte-dominated dermal inflammatory infiltrate accompanied
by dysregulated proliferation and keratinocyte differentiation
(Figure S2; Supplemental Results; Supplemental Discussion).
These findings suggest that damaged or dying keratinocytes
may release danger signals in order to activate the innate
immune system and/or the adaptive immune system.
cFLIP-Deficient Keratinocytes Undergo Apoptosis, but
Not Necroptosis, In Vivo
It has been demonstrated that epidermal loss of caspase-8 or
FADD results in uncontrolled necroptosis (Bonnet et al., 2011;
Kovalenko et al., 2009). In contrast, loss of cFLIP was shown
to result in increased apoptotic cell death in vivo (Zhang and
He, 2005) and in human primary keratinocytes in vitro (Kavuri
et al., 2011). Therefore, we next examined which type of cell
death took place in cFLIP-deficient epidermis. Hematoxylin
and eosin (H&E) staining of skin sections showed hypereosino-
philic suprabasal cells with pyknotic nuclei, indicative of
increased keratinocyte cell death in the epidermis of cFLIPfl/fl-
K14CreERtam mice. Dyskeratosis was rarely detectable at
T48h after acute ablation of cFLIP, but substantially increased
at T72h (Figures 2A and 2E). We next examined skin sections
with an antibody to a cleavage-specific epitope of caspase-3.
Importantly, we were unable to detect dyskeratotic (dying) cells
without concomitant caspase-3 positivity at early and later
time points after initiation of tamoxifen treatment (Figures 2A
and 2B). Cleaved caspase-3-positive cells were first detected
48 hr after the initial tamoxifen application, with a further in-
crease up to 72 hr. Quantification of caspase-3-positive cells
as well as double-staining experiments using cleaved cas-
pase-3 Abs and terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) (Figure 2D) showed that cells with
active caspase-3 were far more numerous predominantly at
earlier time points than dyskeratotic keratinocytes or TUNEL-
positive keratinocytes. In line with our notion of highly increased
levels of apoptotic cell death, electron microscopy of the
epidermis from tamoxifen-treated cFLIPfl/fl-K14CreERtam mice
at T48h and T72h revealed the characteristic features of early
and late apoptosis. Control mice showed a regular stratification
of the epidermis and normal cellular and nuclear morphology. In
contrast, after 48 hr, the keratinocytes of tamoxifen-treated
cFLIPfl/fl-K14CreERtam mice showed numerous cytoplasmic
vacuoles containing organelles indicative of autophagocytosis
(Figure 2C, white arrowheads). Different stages of apoptosis
could be observed in cFLIPfl/fl-K14CreERtam mice, i.e., early
chromatin condensation (black arrowhead), cell shrinkage,
and advanced chromatin condensation (white arrowheads) fol-
lowed by nuclear pyknosis (asterisks). After 72 hr, infiltrating
granulocytes (G) emerged in the epidermis in addition to the
ongoing autophagy and apoptosis (Figure 2C). Taken together,
our data demonstrate that loss of cFLIP in the epidermis results
in a biphasic response. After an initial inflammatory response,
the subsequent dramatic increase of cell death results in loss
of the full thickness of the epidermis, mostly due to apoptotic
cell death. Of note, the presence of one wild-type (WT) allele
of cFLIP was sufficient to protect the epidermis from sponta-
neous apoptosis or caspase activation (Figures 2E and 2F).
These experiments suggest that cFLIP protein expression
from one allele of cFLIP is sufficient to protect epidermal kera-
tinocytes from cell death and a macroscopic phenotype upon
acute ablation of the cFLIP locus.CcFLIP-Deficient Keratinocytes Are Sensitive to
Autocrine TNF-Induced Apoptosis In Vitro
To further mechanistically investigate why keratinocyte cell
death occurs upon acute ablation of cFLIP, we studied cultured
primary murine keratinocytes (PKs) of cFLIPfl/fl-K14CreERtam
mice. Since keratinocytes can undergo either apoptosis or nec-
roptosis (Feoktistova et al., 2011), we further investigated the
sensitivity to CD95L-induced cell death in PKs isolated from
cFLIPfl/fl-K14CreERtam animals upon cFLIP deletion (4-HT) or
diluent-treated cells (control). We demonstrated increased
sensitivity to CD95L-induced cell death (Figures 3C and 3D).
Interestingly, cell death was completely blocked by pretreatment
with zVAD, whereas necrostatin-1 was ineffective in preventing
cell death, indicative of an intrinsic block of RIP1-dependent
death signaling pathways in PKs despite a lack of cFLIP expres-
sion (Figure 3C). However, we observed in these experiments
that the deletion of the cFLIP locus was incomplete in cFLIPfl/fl-
K14CreERtam PK, possibly due to a loss of K14 promoter activity
in vitro (Figure 3A). Therefore, we applied a different experi-
mental approach in which the floxed cFLIP allele was excised
in vitro using lentiviral (LV)-mediated Cre expression in murine
PKs. In cFLIPfl/fl PKs, LV transduction led to complete deletion
of the cFLIP allele (Figures 3A and 3B). Loss of both cFLIP alleles
resulted in loss of cFLIP protein (Figure S3). Complete cFLIP
deletion in PKs resulted in increased spontaneous cell death
(50%–70%) at day 4 posttransduction in PKs isolated from
cFLIPfl/fl-K14CreERtam mice, but not in those isolated from het-
erozygous or WT animals (Figure 3E). These data suggest that
Cre-mediated DNA damage can be excluded as an inducer of
cell death in our experimental system. Moreover, PKs derived
from cFLIPfl/fl and transduced by Cre-LV were exquisitely sensi-
tive to cell death induced by CD95L or TNF (Figure 3F), in line
with data generated using other cell types of cFLIP knockout
or conditional knockout animals (Yeh et al., 2000; Zhang and
He, 2005). To further assess the role of DR signaling in PKs lack-
ing cFLIP, we analyzed the cellular viability of PKs isolated from
homozygous cFLIPfl/fl-K14CreERtam and heterozygous cFLIPfl/+-
K14CreERtam animals in the presence and absence of different
soluble DR fusion proteins. Intriguingly, cFLIP-deficient PKs
were protected from spontaneous cell death by TNF-R2-Fc,
whereas addition of TRAIL-R2-Fc or CD95-Fc was unable to
block cell death (Figure 3G). We reasoned that loss of cFLIP in
our in vitro experimental model based on cFLIP-deficient murine
PKs may promote autocrine TNF production, which ultimately
translates into TNF-induced spontaneous cell death. TNF
mRNA induction and protein secretion of cFLIPfl/fl-K14CreERtam
PKs treated with Cre virus confirmed that TNF induction occurs
as a response to the loss of cFLIP rather than to nonspecific
effects of viral transduction or DNA damage generated by
expression of Cre (Figures 3H and 3I). Taken together, our data
suggest that loss of cFLIP results in increased sensitivity to death
ligand-induced cell death and that induction of autocrine TNF
production driven by loss of cFLIP is sufficient to kill cFLIP-defi-
cient PKs. In this context, we also studied the contribution of
other signaling pathways, such as interleukin-1b (IL-1b) induc-
tion by active caspase-8 (Vince et al., 2012) or lipopolysaccha-
ride (LPS)-induced cell death, as a cause of the epidermal
inflammation (Bannerman et al., 2004). However, neither IL-1bell Reports 5, 397–408, October 31, 2013 ª2013 The Authors 399
Figure 1. Deletion of cFLIP in Epidermal Keratinocytes Results in Early Hyperproliferation and Later Destruction of the Epidermis
(A) Macroscopic aspect of control cFLIP+/+-K14CreERtam mice and cFLIPfl/fl-K14CreERtam mice 10 days after the first tamoxifen application. A representative
mouse and the respective control from a total of ten mice are shown.
(B) Detection of tamoxifen-induced excision of the cFLIP allele (x) in the epidermis. DNAwas isolated fromdifferent organs of cFLIPfl/fl-K14CreERtam and cFLIPfl/+-
K14CreERtam mice and analyzed by multiplex PCR. fl, floxed allele; WT, wild-type allele; x, excised allele.
(C) Schematic representation of the design of the multiplex PCR for detection of the deleted cFLIP allele.
(legend continued on next page)
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nor LPS-induced cell death was modulated by loss of cFLIP
(data not shown). These results indicate that these inflammatory
pathways are of lesser relevance in our model system. Taken
together, the in vitro experiments argue that a TNF-mediated au-
tocrine loop in the skin is the cause of TNF-mediated apoptosis
of cFLIP-deficient PKs in vivo.
Inhibition of Autocrine TNF Signaling Partially Protects
cFLIP-Deficient Epidermis against Early Apoptotic Cell
Death
In order to investigate whether induction of TNF is the cause of
cell death induced by acute cFLIP ablation, we next performed
in vivo experiments using a soluble receptor fusion protein
(recombinant TNF-R2-Fc) to inhibit TNF-dependent signaling.
To that end, we treated cFLIPfl/fl-K14CreERtam animals with
tamoxifen following repetitive injection of TNF-R2-Fc. Mice pre-
treated with TNF-R2-Fc developed weaker, but not completely
abolished, macroscopic skin abnormalities at T96h and T120h
as compared with control animals pretreated with immunoglob-
ulin G (IgG) only (Figure 4A). However, this macroscopic differ-
ence was much less pronounced at later time points, indicating
that additional signaling pathways become operative for cell
death independently of TNF signaling. Histological analysis of
skin sections from TNF-R2-Fc pretreated mice at T72h and
T96h also showed a (nonsignificant) tendency to decreased
hyperkeratosis, acanthosis, pustule formation, epidermal disin-
tegration, etc., as compared with control IgG-pretreated animals
(Figures 4B and 4E). Staining of active caspase-3, however,
demonstrated a significant decrease in the number of apoptotic
keratinocytes in the TNF-R2-Fc-treated animals at T72h (Figures
4C and 4D). Thus, it seems likely that epidermal cell death in
cFLIPfl/fl-K14CreERtam mice is mediated by paracrine or auto-
crine TNF. In this model, TNF may be produced by either infil-
trating cells or in an autocrine manner by keratinocytes, as
suggested by our in vitro and in vivo studies. Acute loss of
cFLIP in the epidermis therefore initiates early TNF-dependent
responses, which suggests that cFLIP is a critical inhibitor of
TNF-mediated cell death in the skin.
Epidermal cFLIP Expression Is Lost Concomitantly with
Increased Caspase-8 Activation in Skin Disease
Associated with Epidermal Cell Death
Given the dramatic cell death phenotype of cFLIP-depleted
mouse skin that was evident within 48–72 hr after cFLIP locus
deletion, we reasoned that cFLIP may represent a major road-
block to epidermal cell death in human skin disease. We thus
next investigated disease entities that have long been known(D) Skin sections at the indicated time points from control cFLIP+/+-K14CreERtam a
Scale bars represent 50 mm.
(E) Skin sections from tamoxifen-treated cFLIPfl/fl-K14CreERtam and control cF
respectively. cFLIP Abs (H-202) stained the epidermis of control animals, but did n
pattern was controlled for by genetic typing (data not shown) and was seen at a
suitable for the detection ofmurine cFLIP bywestern blotting (Figure S3). Scale ba
a total of 23 mice.
(F) Skin sections from control cFLIP+/+-K14CreERtam mice and cFLIPfl/fl-K14Cre
histological features, such as pustule formation, epidermal disintegration, and app
a total of 20 analyzed mice and their respective controls.
See also Figures S1 and S2.
Cto be associated with increased cell death in the skin, namely,
TEN/SJS (Harr and French, 2012), EEM, and cutaneous lupus
erythematodes (CLE). We detected a strong cFLIP expression
in the basal layer of healthy skin (Figure 5A, healthy skin). In
contrast, detectable caspase-8 cleavage, as determined by
staining of a cleavage-generated neoepitope of this caspase,
was absent in healthy skin. Interestingly, epidermal staining of
cFLIP was substantially decreased in lesional skin of patients
with TEN/SJS and EEM, whereas lesional skin of CLE patients
did not show a loss of cFLIP (Figure 5A, right), consistent with
a granzymeB-mediated form of cell death in this disease, as pro-
posed by Wenzel and Tu¨ting (2008). Concomitantly, increased
cleaved (active) caspase-8 was detected in these skin regions,
as also indicated by double stainings of cFLIP and caspase-8
(Figure 5A, right). Our data indicate that epidermal loss of cFLIP
in keratinocytes may be an important prerequisite for the
increased caspase-8-mediated epidermal cell death seen in
patients with TEN/SJS.
DISCUSSION
Tight control of the programmed cell death machinery is of crit-
ical importance to ensure undisturbed skin development and the
maintenance of skin homeostasis. Whereas early studies that
examined the role of DRs focused on the elicitation of cell death
(Strasser et al., 2000), more recent studies highlighted the fact
that DR signaling pathways and their apical signaling molecules
have additional important functions beyond the mere initiation of
cell death responses. This includes activation of signals such as
NF-kB and gene induction of cytokines and chemokines (Lever-
kus et al., 2003; Cullen et al., 2013). Moreover, it was shown that
caspase-8 regulates wound-healing responses (Lee et al., 2009)
and downregulates metastasis in cancer cells (Stupack et al.,
2006). We previously suggested that the control of inflammatory
responses of the skin to allergens or other extrinsic ‘‘danger sig-
nals’’ may be profoundly influenced by the qualitative outcome of
DR triggering in the skin, because DR-induced inflammatory
signaling (e.g., activation of the transcription factor NF-kB) may
impact skin diseases (Kerstan et al., 2009; Leverkus and Traut-
mann, 2006). When one considers the numerous functions of
caspase-8, it is evident that the procaspase-8-like, protease-
deficient homolog cFLIP is of great interest as a central regulator
of caspase-8 function. Here, we investigated the role of cFLIP in
the skin in vivo. Constitutive ablation of the cFLIP gene using
K14-Cre mice revealed that loss of cFLIP is lethal during embry-
onic life, which is indicative of its importance during skin devel-
opment. Because constitutive ablation may result in a multitudend cFLIPfl/fl-K14CreERtammice stained with H&E, cFLIP, K14, K10, and loricrin.
LIP+/+-K14CreERtam mice at T72H were stained with H&E and Abs to cFLIP,
ot label the epidermis of animals with epidermal deletion of cFLIP. This staining
ntibody concentrations up to 5 mg/ml. However, cFLIP Abs (H-202) were not
rs represent 100 mm.Data presented in (D) and (E) are representative slides from
ERtam 96 hr after initiation of tamoxifen treatment, stained with H&E. Different
earance of subepidermal blisters (arrow), are shown. Data are representative of
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Figure 2. cFLIP Protects against Epithelial Apoptotic Cell Death In Vivo
(A) Skin sections at the indicated time points from control cFLIP+/+-K14CreERtam and cFLIPfl/fl-K14CreERtam mice were stained with H&E or Abs to cleaved
caspase-3, respectively. Asterisks indicate nonspecific staining. Scale bars represent 50 mm. The data are representative of a total of 26 mice.
(B) Quantification of caspase-3-positive cells per microscopic field at the indicated time points from cFLIPfl/fl-K14CreERtam mice compared with controls. A total
of 12 mice were analyzed.
(C) The skin of control and cFLIPfl/fl-K14CreERtam mice was investigated by transmission electron microscopy after 48 and 72 hr. Basement membranes are
highlighted by a dotted yellow line. Scale bars correspond to 2 mm. The data shown are representative of ten analyzed animals.
(legend continued on next page)
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Figure 3. cFLIP Deletion In Vitro Results in
Increased Sensitivity to Death-Ligand-
Induced Cell Death of PKs and Is Caused
by TNF-Induced Apoptosis
(A) Comparison of cFLIP allele deletion in PKs
isolated from cFLIPfl/fl-K14CreERtam mice. The
comparison of cells treated with either 4-HT or LV-
Cre transduction is shown. Isolated DNA was
analyzed by multiplex PCR. Asterisks indicate
nonspecific bands. The data shown are repre-
sentative of five independent experiments. fl,
floxed; WT, wild-type; x, excised allele.
(B) Western blot for cFLIP and caspase-8 of con-
trol-LV and Cre-LV transduced PKs isolated from
cFLIPfl/fl-K14CreERtam mice. The western blot
shown is representative of two independent
experiments.
(C) Cellular viability of PKs isolated from cFLIPfl/fl-
K14CreERtammice treated as indicated. Error bars
represent the SEM of eight independent experi-
ments.
(D) cFLIPfl/fl-K14CreERtam mice were treated as
indicated and assayed by crystal violet staining.
Error bars represent the SEM of two independent
experiments.
(E) Control-LV and Cre-LV transduced PKs
isolated from cFLIP+/+-K14CreERtam, cFLIPfl/+-
K14CreERtam, and cFLIPfl/fl-K14CreERtam were
treated as indicated. Error bars represent the SEM
of three independent experiments.
(F) PKs of cFLIPfl/fl-K14CreERtam mice were in-
fected with control-LV or Cre-LV and treated as
indicated. Error bars represent the SEM of three
independent experiments.
(G) cFLIPfl/fl-K14CreERtam and cFLIPfl/+-
K14CreERtam mice were Cre-LV transduced and
treated as indicated. Error bars represent the
SEM of three independent experiments.
(H) PKs isolated from cFLIP+/+-K14CreERtam,
cFLIPfl/+-K14CreERtam, and cFLIPfl/fl-K14CreERtam
mice were transduced with control-LV and
Cre-LV. At T72h, cell-free culture supernatants
were analyzed for TNF production by ELISA.
Error bars represent the SEM of two inde-
pendent experiments. In (C)–(H), *p < 0.05 and
**p < 0.01.
(I) mRNA expression of TNF in control andCre-LV transduced PKs isolated from cFLIP+/+-K14CreERtam, cFLIPfl/+-K14CreERtam, and cFLIPfl/fl-K14CreERtammice.
Error bars represent the SEM of two independent experiments. All experiments with PKs were performed with pooled cells from four to six animals per pool.
See also Figure S3.of secondary effects in the developing skin or in the early post-
natal period, we decided to focus on the acute deletion of cFLIP
from adult skin. We found that within days, loss of cFLIP
disturbed skin homeostasis, and this was associated with a
dual response. At early time points, an inflammatory response
with marked acanthosis accompanied by infiltration of T cells(D) Skin sections at the indicated time points from control cFLIP+/+-K14CreER
caspase-3. Scale bars represent 100 mm.Quantification of cleaved caspase-3- or
Inset shows higher magnification. A total of nine mice were analyzed.
(E) Skin sections of cFLIPfl/+-K14CreERtam and cFLIPfl/fl-K14CreERtam mice 72 h
caspase-3. Scale bars represent 100 mm. The data shown are representative of
(F) Quantification of caspase-3-positive cells per microscopic field of skin section
of 12 mice were analyzed. *p < 0.05, **p < 0.01.
Cand neutrophils was followed by a marked increase in dyskera-
totic keratinocytes in the epidermis. As early as 4 days after initi-
ation of cFLIP deletion, we detected subepidermal blisters,
pustules, and ultimately complete loss of the epidermis. These
data demonstrate that cFLIP is indispensable for skin homeo-
stasis and protects against cell death. The macroscopic skintam and cFLIPfl/fl-K14CreERtam mice with double staining of TUNEL/cleaved
TUNEL-positive cells per microscopic field of the double-stained skin sections.
r after initiation of tamoxifen treatment, stained with H&E and Abs to cleaved
ten analyzed animals.
s from cFLIPfl/+-K14CreERtam and cFLIPfl/fl-K14CreERtam mice at T72h. A total
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Figure 4. cFLIP-Deficient Epidermis Is Pro-
tected from Early Caspase-3 Activation and
Cell Death by TNF-R2-Fc
(A) Macroscopic appearance of FLIPfl/fl-
K14CreERtam mice 5 days after the first tamoxifen
application after TNF-R2-Fc (TNFR2-Fc) or IgG
pretreatment, respectively. A total of six mice were
analyzed for this time point. A representative pic-
ture is shown.
(B) Skin sections stained with H&E at T72h and
T96h. Scale bars represent 100 mm. A total of 20
animals were analyzed and four different exam-
ples are shown for each time point/condition.
(C) Quantification of caspase-3-positive cells per
microscopic field of skin sections from cFLIPfl/fl-
K14CreERtam mice at T72h pretreated with TNF-
R2-Fc or IgG, respectively. Skin sections of a total
of ten animals treated with either IgG or TNF-R2-
Fc were analyzed.
(D) Representative skin sections from cFLIPfl/fl-
K14CreERtam mice at T72h pretreated with TNF-
R2-Fc or IgG stained with active caspase-3
antibody.
(E) Semiquantitative analysis of H&E pathological
scoring as outlined in Experimental Procedures. A
total of 20 animals (ten treated with TNF-R2-Fc
[TNFR2-Fc] and ten treated with IgG) were
analyzed.phenotype was accompanied by the rapid appearance of cas-
pase-3 activity in the epidermis, which was detectable prior to
the profound histological changes of cFLIP-deficient skin. More-
over, electron microscopy further supported the apoptotic
phenotype of cFLIP-deficient keratinocyte death. Taken
together, our morphological studies demonstrate that acute
loss of cFLIP results in fulminant apoptosis, but not necroptosis,
of the epidermis within days. Our data contrast with interesting
reports that necroptosis in the skin was evident in either consti-
tutive caspase-8- or FADD-deficient skin that contained
numerous dyskeratotic keratinocytes a few days after birth (Bon-
net et al., 2011; Kovalenko et al., 2009) but lacked active cas-
pase-3 (Bonnet et al., 2011). This implies that the predominant
function of caspase-8 is antinecroptotic rather than antiapop-
totic, at least upon chronic deletion of FADD or caspase-8. In
contrast to these findings, acute loss of cFLIP in the skin reveals
that a major function of cFLIP in vivo is to protect against
epidermal apoptosis. The disparate effects of cFLIP and cas-
pase-8 were also recently highlighted in a developmental mouse
model. Whereas acute or chronic loss of caspase-8 was rescued
by concomitant loss of RIP3, a major effector of necroptosis, the404 Cell Reports 5, 397–408, October 31, 2013 ª2013 The Authorsconstitutive or acute removal of cFLIP
was not rescued by the accompanying
loss of RIP3 (Dillon et al., 2012; Weinlich
et al., 2013). It is therefore tempting
to speculate that apoptosis, rather than
necroptosis, is the predominant mode of
cell death during development when
cFLIP is absent. Our data from a post-
natal model of acute deletion of cFLIP inthe skin further support the notion that cFLIP primarily serves
an antiapoptotic function, in contrast to the strikingly different
function of caspase-8 in the epidermis.
It remains to be dissected how the striking macroscopic and
microscopic phenotypes of cFLIP-deficient skin are ruled at
the molecular level. We investigated this important question us-
ing several in vitro model systems. Primary cFLIP-deficient PKs
showed an increased sensitivity to death ligands, exemplified by
CD95L or TNF. Moreover, enforced deletion of cFLIP in most
PKs by LV-Cre infection resulted in more than 50% spontaneous
cell death that was largely blocked by TNF inhibition, but not by
either CD95L or TRAIL blockade. These in vitro experiments
argue that a TNF-mediated autocrine loop in the skin is required
to initiate TNF-mediated apoptosis of cFLIP-deficient PKs in vivo.
Inhibition of TNF in vivo by TNF-R2-Fc protected against early
inflammation, caspase-3 activation, and cell death, and reduced
the early extent of skin disease. This argues for an important role
of TNF in the early phase of skin disease and suggests that a
major function of cFLIP is to protect keratinocytes against
TNF-induced apoptosis in vivo. Our data are in line with results
from mice lacking caspase-8 or FADD in the skin. In these
Figure 5. Epidermal cFLIP Expression Is
Lost Concomitantly with Increased Cas-
pase-8 Activation in Skin Disease Associ-
ated with Excessive Epidermal Cell Death
(A) Serial skin sections (left) or representative
skin sections (cFLIP/caspase-8 double staining)
of patients with TEN/SJS, EEM, or CLE were
stained with Abs to cFLIP and cleaved cas-
pase-8, and compared with the expression in
healthy skin.
(B) Semiquantitative analysis of cFLIP expression
in a series of patients. Relative expression was
evaluated by three independent investigators as
described in Experimental Procedures. Black bars
identify histopathology scoring > 0, and white bars
depict scoring < 0.animals, TNF or TNF-R1 deletion delayed the macroscopic
phenotype, but did not prevent it at later time points (Bonnet
et al., 2011; Kovalenko et al., 2009). Therefore, it is most likely
that alternative cFLIP-inhibited pathways contribute to the
macroscopic phenotype following acute ablation of cFLIP in
keratinocytes. Our data suggest that early induction of TNF in
the skin and subsequent TNF-induced apoptosis represent a
major mechanism of dramatic epidermal cell death in our mouse
model.
In combination, the kinetics of skin morphology and the
pattern of molecular changes in PKs suggest the following
mechanism of cell death in our mouse model: initial apoptotic
cell death caused by loss of cFLIP triggers the development of
an inflammatory skin disease that precedes the disintegration
of the epidermis. In this regard, the earliest detectable event
after initiation of tamoxifen treatment was the appearance of
inflamed skin around 3 days after initiation of cFLIP locus dele-
tion (Figure S2A). The remaining cFLIP protein may then beCell Reports 5, 397–408,able to protect against TNF death
signaling for this period of time. However,
TNF may already have been induced in
the epidermis at earlier time points, as
suggested by our in vitro studies. The
early expression of TNF may explain the
inflammatory response in cells that do
not die in our model, because TNF com-
plex II is still inhibited by the remaining
cellular levels of cFLIP protein (Micheau
and Tschopp, 2003).
How can the endogenous caspase-8
inhibitor cFLIP block apoptosis and not
allow for necroptosis in vivo? Our current
findings and previous biochemical work
using different cFLIP isoforms (Feoktis-
tova et al., 2011; Geserick et al., 2009),
together with elegant evidence from
mouse genetics (Oberst et al., 2011),
suggest the following scenario: cFLIP is
critically needed to guide and keep
the enzymatic activity of the cFLIP/cas-
pase-8 heterodimer within different deathsignalingplatforms. In thesesignalingplatforms, caspase-8 activ-
ity associated with the uncleaved caspase-8/cFLIP heterodimer
is needed to inhibit necroptosis, most likely by cleavage of RIP1
(Feoktistova et al., 2011; O’Donnell et al., 2011; Rajput et al.,
2011). RIP1 cleavage thus interfereswith the assembly or stability
of the necrosome, ripoptosome, TNF complex II, or RIG-I com-
plex, thereby blocking necroptosis. If this important function of
caspase-8 within these signaling complexes is not maintained
by its heterodimer with cFLIPL, caspase-8 is further autopro-
cessed to heterotetramers and released from these death plat-
forms. In the absenceof cFLIP, apoptosiswithout overt necropto-
sis is found,andamajor functionof cFLIP is to keep thecaspase-8
activity localized within the death platforms. Regardless of the
exact stimulus of death-platform assembly after cFLIP deletion
in the epidermis (beyond TNF complex II, as suggested by our in-
hibition studies), the lack of cFLIP protein promotes rapid and
fulminant apoptosis. The resulting high caspase activity outside
of theassembleddeathplatforms then inhibits further necroptosisOctober 31, 2013 ª2013 The Authors 405
signaling, likelybyRIP1andRIP3cleavage (Fengetal., 2007;Mar-
tinon et al., 2000). The fact that autocrine TNF is associated with
the early phenotype and is spontaneously induced after cFLIP
loss in cultured PKs suggests a critical function of cFLIP in the
blockade of TNF complex II, as previously suggested (Micheau
and Tschopp, 2003). In the future, it will be interesting to study
the role of mitogen-activated protein kinase (MAPK) and the
NF-kB signaling pathways in TNF transcription andmRNA stabil-
ity upon cFLIP deletion in keratinocytes (Leverkus et al., 1998).
Our data highlight that tissue distribution of the core proteins of
the death signaling complexes (including cFLIP, caspase-8,
FADD, RIP1, and other known or unknown proteins) of both
apoptosis and necroptosis pathways determine the outcome of
cellular stresssignals, includingTNF.For example, tissue-specific
constitutive knockout of cFLIP in the liver produced divergent
results, with either no spontaneous disease (Schattenberg et al.,
2011) or perinatal death (Piao et al., 2012), whereas liver-specific,
cFLIP-deficient animals rapidly succumbed to fulminant hepatitis
uponpoly I:C challenge in a TNF-, TRAIL-, andCD95L-dependent
manner generated most likely by Kupffer cells. In contrast, dele-
tion of cFLIP in intestinal epithelial cells resulted in perinatal
lethality (Piao et al., 2012), whereas cFLIPL deficiency in T lym-
phocytes led to altered regulation of apoptosis, autophagy, and
necroptosis (He and He, 2013). This suggests that epithelial cells
may be particularly susceptible to loss of cFLIP, as shown in our
study in keratinocytes. It is possible that epithelial cells are partic-
ularly vulnerable to loss of cFLIP due to their constant encounters
with noxious stimuli that activate pattern-recognition receptors
(PRRs), DRs, or the RIG-I signaling complex.
Previous reports indicated that the fulminant cell death pheno-
type seen in patients with TEN is induced by the death ligand
CD95L (Viard et al., 1998) or granulysin produced by subsets
of natural killer (NK) or CD8 T cells (Chung et al., 2008). Our
data now add to this body of evidence by indicating that
epidermal loss of cFLIP in keratinocytes may be an important
prerequisite for the dramatic cell death seen in patients with
TEN/SJS. This suggests that additional signals induced by the
quality and/or quantity of infiltrating immune cells mediate cFLIP
protein loss and subsequent fulminant epidermal cell death in
these diseases. Our data highlight that cFLIP is necessary to pro-
tect against excessive apoptosis in the epidermis and is a poten-
tial target of therapeutic efforts (i.e., by transcriptional induction
or posttranslational upregulation of cFLIP) in these potentially
life-threatening diseases. Although this conclusion is based on
only indirect and correlative evidence obtained from patients
with TEN/SJS as compared with patients with CLE, the dramatic
phenotype of cFLIP-deficient mouse skin resembling TEN after
acute loss of cFLIP renders it an attractive possibility. Taken
together, our findings provide insights into the regulation of the
cell death machinery of the epidermis and warrant future studies
to dissect the impact of loss of cFLIP in a number of inflammatory
and neoplastic diseases of the skin.EXPERIMENTAL PROCEDURES
Mice
Transgenic mice expressing Cre under the control of the K14 promoter, mice
with conditional K14-Cre expression, and mice carrying the loxP FLIP allele406 Cell Reports 5, 397–408, October 31, 2013 ª2013 The Authorswere previously described (Hafner et al., 2004; Vasioukhin et al., 1999; Zhang
andHe, 2005). To generate knockout mice with epidermal-specific cFLIP dele-
tion, we bred floxed cFLIP to either K14-Cre or K14CreERtam mice. Cre
expression was induced by the application of tamoxifen (Sigma). The back
skin of the mice was treated daily with a 100 ml ethanol solution of tamoxifen
at a concentration of 25 mg/ml for 5 consecutive days. Control animals ex-
pressing Cre but lacking loxP-flanked alleles were included in all experiments.
Histology and Immunohistochemistry
Formalin-fixed and paraffin-embedded tissues were used for all histopatho-
logical and immunofluorescence studies of murine skin. We used the following
antibodies: K14, K6, K10, and Loricrin (Covance); cleaved caspase-3 (Asp175;
Cell Signaling); cleaved caspase-8 (Asp391) clone 18C8; Cell Signaling);
and cFLIP (H202; Santa Cruz). Secondary biotinylated antibody and Cy2-
Streptavidin were purchased from Vector Laboratories and Jackson
ImmunoResearch, respectively. The TUNEL assay was obtained from Milli-
pore. Image processing was applied identically to all samples and controls.
Quantification of Immunohistochemical or Immunofluorescent
Labeling of Histological Slides
Skin sections were semiquantitatively evaluated by three independent investi-
gators blinded to the treatment of the respective mouse in at least 30–40 fields
of each sample. Pathological changes of the epidermis (H&E staining) were
scored as 0 (healthy skin), 1 (single dead cells, hyperkeratosis, acanthosis),
2 (small regions of confluent cell death, small ulcers, subepidermal blistering),
3 (wide ulcers, wide regions of confluent cell death per microscopic field), or 4
(fully disintegrated epidermis).
Electron Microscopy
The skin was fixed in Karnovsky’s glutaraldehyde (2% paraformaldehyde,
2.5% glutaraldehyde, 0.2 M cacodylate buffer pH 7.4) and embedded in aral-
dite (Serva). Ultrathin sections were stained with lead citrate and uranyl ace-
tate. Photographs were taken on a transmission electron microscope (Zeiss
EM 900; Carl Zeiss).
Primary Keratinocyte Isolation and Cell Death Assays
PKs were isolated from the skin of newborn cFLIPfl/fl K14CreERtam mice and
cultured for 5 days in CnT-07 medium (CELLnTEC). Cre expression was
induced with 100 mM 4-HT. The prestimulation and stimulation conditions
were as follows: zVAD (10 mM), Necrostatin-1 (Nec-1; 50 mM), TNF-R2-Fc
(10 mg/ml), TRAIL-R2-Fc (10 mg/ml), CD95-Fc (10 mg/ml), TNF (10 ng/ml),
and agonistic CD95L-Fc (625 U/ml).
LV Expression of Cre in PKs and Immunoblotting
The pFU Cre SV40 puroW construct was kindly provided by John Silke (WEHI,
Melbourne, Australia). Cre-LV was generated in human embryonic kidney
(HEK) cells. Total protein was probed with cFLIP (clone Dave-2; Apotech)
and caspase-8 (clone 1G12; Axxora).
Statistical Analysis
The SEMwas determined for three to five independent experiments performed
with PKs pooled from three to five newborn animals for each experiment.
Student’s t test was used for statistical data analysis. Significance is stated
whenever the p value was < 0.05.
RNA Isolation and Real-Time qPCR
RNA isolation from skin or cultured PKs, respectively, was performed with the
RNeasy Kit (QIAGEN). cDNA was synthesized by SuperScript II Reverse Tran-
scriptase (Invitrogen) using a mixture of random nonamers and oligo dT
primers. Each experiment was normalized to b-actin expression.
Patient Specimens
Cryosections of patients were obtained either from healthy donors or from
patients with EEM, TEN, or CLE as approved by the ethics committee of the
University of Wu¨rzburg Medical School. Slides were examined on an Olympus
BX41 microscope (Olympus) at constant illumination settings. The staining in-
tensity was semiquantitatively evaluated by three independent observers at
2003magnification. Epidermal expression of cFLIP was scored as 0 (no differ-
ence), 1 (1%–33% reduction), 2 (34%–66% reduction), or 3 (67%–100%
reduction), and vice versa for increased expression as compared with healthy
skin or normal skin appearing at themargins of the biopsy. Double stainingwas
performed by sequential incubation and development of cFLIP and caspase-8
using the polymerized peroxidase enzyme staining system (ImmPRESS; Vec-
tor Laboratories). 3-Amino-9-ethylcarbazole (AEC) and Vector SG were used
as substrates, followed by counterstaining with hematoxylin. Sections incu-
bated with the appropriate isotype monoclonal antibody or polyclonal rabbit
IgG were used as negative controls.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental Results, Supplemental Discussion, three figures, and two tables
and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.
2013.09.035.
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